An observational study in SBS - Short Bowel Syndrome, sponsored by Central Hospital, Nancy, France. Status unknown at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-11-04.
Sponsored by Central Hospital, Nancy, France · Observational
Today, patients express a very strong need to take into account the consequences of their disease and its treatments in their therapeutic follow-up. It is therefore essential to better understand the needs, expectations and values of patients with SBS in order to better understand the impact of the disease on their lives, and thus improve the conditions for medical, social, psychological and technical care. The clinical expertise of health professionals and meetings with patient associations demonstrate the major gap between the parameters taken into account by physician to evaluate the evolution of the SBS and the day-to-day experience of the disease perceived by the patient.
The objective of the ARTEMIS-GC study is to develop and validate an instrument to measure the impact of SBS and its treatments on daily life from the perspective of patients.
149 studies on the registry are indexed under Short Bowel Syndrome; 25 are open to participants now.
This study's planned enrollment of 250 is above the median of 53 across 36 observational studies indexed under Short Bowel Syndrome.
Browse Short Bowel Syndrome studies →Central Hospital, Nancy, France is the lead sponsor of 778 studies on the registry; 183 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients over 18 years with SBS for more than 6 months and returned home for at least 3 months.
Exclusion Criteria:
Exploratory interviews to generate an interview guide
Semi-directive interviews to collect qualitative data that will be used for questionnaire item generation
Cotation of newly developed items pertinence on a 4 points likert scale.
Debriefing session for the newly developed items: final possibility to adjust the tool before validating the psychometric proprieties of the questionnaire.
Psychometric properties study
Scale calibration of the new developped questionnaire
Calibration measure
Time frame: about 30 minutes
Structure of the new developped questionnaire
Structure identification
Time frame: about 30 minutes
Convergence proprieties of the new developped questionnaire
Convergence evaluation
Time frame: about 30 minutes
Reproducibility of the new developped questionnaire
Test of reproducibility
Time frame: Up to 8 days
Plan to share: Undecided
No publications or documents are linked to this record.
This study is status unknown, as verified in Sep 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Central Hospital, Nancy, France